Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZYCUBO safely and effectively. See full prescribing information for ZYCUBO. ZYCUBO® (copper histidinate) for injection, for subcutaneous useInitial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
ZYCUBO is indicated for the treatment of Menkes disease in pediatric patients. Limitations of Use ZYCUBO is not indicated for the treatment of Occipital Horn Syndrome.
- generic_name
- copper histidinate
- product_names
- copper histidinate
- ndc
- 42358-329, 42358-329-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en